Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1990 Feb;58(2):536–542. doi: 10.1128/iai.58.2.536-542.1990

Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.

S Nagao 1, M Nakanishi 1, H Kutsukake 1, K Yagawa 1, S Kusumoto 1, T Shiba 1, A Tanaka 1, S Kotani 1
PMCID: PMC258490  PMID: 2298491

Abstract

N-Acetylmuramyl-L-alanyl-D-isoglutamine (muramyl dipeptide [MDP]) injected intraperitoneally significantly increased the number of cells entering the peritoneal cavity of guinea pigs primed with liquid paraffin or thioglycollate. There was a close relationship between peritoneal polymorphonuclear leukocyte (PMN) accumulation and the uptake of glucosamine by macrophages in guinea pigs treated with a variety of bacterial cell surface components such as cell wall peptidoglycan subunits and bacterial or synthetic lipid A. The PMN accumulation was also facilitated by the intraperitoneal transfer of the peritoneal macrophages that had been stimulated by MDP in vitro. Furthermore, cell-free lavage fluids taken from the peritoneum of MDP-treated guinea pigs also initiated the influx of PMNs when introduced into the peritoneal cavities of liquid paraffin-pretreated guinea pigs. These results suggest that a soluble factor which attracts neutrophils is produced by MDP-treated macrophages. Partial characterization of the factor is described.

Full text

PDF
542

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohn Z. A. Activation of mononuclear phagocytes: fact, fancy, and future. J Immunol. 1978 Sep;121(3):813–816. [PubMed] [Google Scholar]
  2. FINDLAY J., LEVVY G. A. Purification of beta-N-acetylglucosaminidase from the pig epididymis. Biochem J. 1960 Oct;77:170–175. doi: 10.1042/bj0770170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goetzl E. J., Pickett W. C. Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B. J Exp Med. 1981 Feb 1;153(2):482–487. doi: 10.1084/jem.153.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harada K., Kotani S., Takada H., Tsujimoto M., Hirachi Y., Kusumoto S., Shiba T., Kawata S., Yokogawa K., Nishimura H. Liberation of serotonin from rabbit blood platelets by bacterial cell walls and related compounds. Infect Immun. 1982 Sep;37(3):1181–1190. doi: 10.1128/iai.37.3.1181-1190.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hsueh W., Sun F. F. Leukotriene B4 biosynthesis by alveolar macrophages. Biochem Biophys Res Commun. 1982 Jun 30;106(4):1085–1091. doi: 10.1016/0006-291x(82)91223-2. [DOI] [PubMed] [Google Scholar]
  6. Kaku M., Yagawa K., Nagao S., Tanaka A. Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide. Infect Immun. 1983 Feb;39(2):559–564. doi: 10.1128/iai.39.2.559-564.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kharazmi A., Nielsen H., Bendtzen K. Recombinant interleukin 1 alpha and beta prime human monocyte superoxide production but have no effect on chemotaxis and oxidative burst response of neutrophils. Immunobiology. 1988 Apr;177(1):32–39. doi: 10.1016/s0171-2985(88)80089-5. [DOI] [PubMed] [Google Scholar]
  8. Kotani S., Takada H., Tsujimoto M., Ogawa T., Takahashi I., Ikeda T., Otsuka K., Shimauchi H., Kasai N., Mashimo J. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect Immun. 1985 Jul;49(1):225–237. doi: 10.1128/iai.49.1.225-237.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kotani S., Tsujimoto M., Koga T., Nagao S., Tanaka A., Kawata S. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc. 1986 Oct;45(11):2534–2540. [PubMed] [Google Scholar]
  10. Kotani S., Watanabe Y., Shimono T., Kinoshita F., Narita T. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum. Biken J. 1975 Jun;18(2):93–103. [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Lefrancier P., Derrien M., Jamet X., Choay J., Lederer E., Audibert F., Parant M., Parant F., Chedid L. Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides. J Med Chem. 1982 Jan;25(1):87–90. doi: 10.1021/jm00343a018. [DOI] [PubMed] [Google Scholar]
  13. Luger T. A., Charon J. A., Colot M., Micksche M., Oppenheim J. J. Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol. 1983 Aug;131(2):816–820. [PubMed] [Google Scholar]
  14. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ming W. J., Bersani L., Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1987 Mar 1;138(5):1469–1474. [PubMed] [Google Scholar]
  16. Mrowietz U., Schröder J. M., Christophers E. Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1223–1228. doi: 10.1016/s0006-291x(88)81358-5. [DOI] [PubMed] [Google Scholar]
  17. Nagao S., Miki T., Tanaka A. Macrophage activation by muramyl dipeptide (MDP) without lymphocyte participation. Microbiol Immunol. 1981;25(1):41–50. doi: 10.1111/j.1348-0421.1981.tb00005.x. [DOI] [PubMed] [Google Scholar]
  18. Nagao S., Takada H., Yagawa K., Kutsukake H., Shiba T., Kusumoto S., Kawata S., Hasegawa A., Kiso M., Azuma I. Structural requirements of muramylpeptides for induction of necrosis at sites primed with Mycobacterium tuberculosis in guinea pigs. Infect Immun. 1987 May;55(5):1279–1288. doi: 10.1128/iai.55.5.1279-1288.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nagao S., Tanaka A. Inhibition of macrophage DNA synthesis by immunomodulators. I. Suppression of [3H]thymidine incorporation into macrophages by MDP and LPS. Microbiol Immunol. 1983;27(4):377–387. doi: 10.1111/j.1348-0421.1983.tb00596.x. [DOI] [PubMed] [Google Scholar]
  20. Nagao S., Tanaka A., Yamamoto Y., Koga T., Onoue K., Shiba T., Kusumoto K., Kotani S. Inhibition of macrophage migration by muramyl peptides. Infect Immun. 1979 May;24(2):308–312. doi: 10.1128/iai.24.2.308-312.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. North R. J. The concept of the activated macrophage. J Immunol. 1978 Sep;121(3):806–809. [PMC free article] [PubMed] [Google Scholar]
  22. Peveri P., Walz A., Dewald B., Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med. 1988 May 1;167(5):1547–1559. doi: 10.1084/jem.167.5.1547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Takada H., Tsujimoto M., Kato K., Kotani S., Kusumoto S., Inage M., Shiba T., Yano I., Kawata S., Yokogawa K. Macrophage activation by bacterial cell walls and related synthetic compounds. Infect Immun. 1979 Jul;25(1):48–53. doi: 10.1128/iai.25.1.48-53.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wolpe S. D., Davatelis G., Sherry B., Beutler B., Hesse D. G., Nguyen H. T., Moldawer L. L., Nathan C. F., Lowry S. F., Cerami A. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med. 1988 Feb 1;167(2):570–581. doi: 10.1084/jem.167.2.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Yagawa K., Kaku M., Ichinose Y., Nagao S., Tanaka A., Aida Y., Tomoda A. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide. J Immunol. 1985 Jun;134(6):3705–3711. [PubMed] [Google Scholar]
  26. Yamamoto Y., Nagao S., Tanaka A., Koga T., Onoue K. Inhibition of macrophage migration by synthetic muramyl dipeptide. Biochem Biophys Res Commun. 1978 Feb 28;80(4):923–928. doi: 10.1016/0006-291x(78)91333-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES